Accelerate your cell and gene therapy development
27 Sept 2023
The promise of cell and gene therapies as the next generation cure for oncological and rare inherited genetic diseases is being realized. Their potential has driven a rapid expansion in both preclinical and clinical research and development.
The increasing complexity of cell and gene therapy genomic edits required to treat multifactorial diseases, and the need for precision-targeted delivery systems, is driving continual innovation aimed at expediting the availability of these life-saving treatments to patients.
This infographic provides an overview of Revvity's comprehensive cell and gene therapy solutions, emphasizing the role of innovation and automation in streamlining the therapy development workflow.
